시장보고서 | 연간정보서비스 | 맞춤형시장조사 | 메일링 | 비교리스트
세계의 간질 발작 치료 시장 보고서(2025년)
Epileptic Seizures Treatment Global Market Report 2025
상품코드 : 1704295
리서치사 : The Business Research Company
발행일 : On Demand Report
페이지 정보 : 영문 200 Pages
 라이선스 & 가격 (부가세 별도)
US $ 4,490 ￦ 6,339,000
PDF (Single User License) help
PDF 보고서를 1명만 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.
US $ 6,490 ￦ 9,163,000
PDF (Site License) help
PDF 보고서를 동일 사업장의 모든 분이 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.
US $ 8,490 ￦ 11,987,000
PDF (Enterprise License) help
PDF 보고서를 동일 기업의 모든 분이 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.


ㅁ Add-on 가능: 고객의 요청에 따라 일정한 범위 내에서 Customization이 가능합니다. 자세한 사항은 문의해 주시기 바랍니다.
ㅁ 보고서에 따라 최신 정보로 업데이트하여 보내드립니다. 배송기일은 문의해 주시기 바랍니다.

한글목차

간질 발작 치료 시장 규모는 향후 수년간 강력한 성장세를 보일 것으로 예상되며, 2029년까지 연평균 6.6%의 성장률로 47억 2,000만 달러에 달할 것으로 예상됩니다. 예측 기간 중의 성장은 정밀의료 접근법, 새로운 치료 방식, 원격의료 및 원격 모니터링, 의료 통합 및 다학제 진료, 규제 지원 및 인센티브에 기인합니다. 예측 기간 중 주요 동향으로는 맞춤형 의료, 디지털 헬스 솔루션의 통합, 새로운 치료법, 동반 질환과 삶의 질에 대한 관심, 규제 지원 및 시장 진입 등이 있습니다.

간질 발병률 증가는 간질 발작 치료제 시장의 향후 성장을 가속할 것으로 예상됩니다. 간질은 재발성 비유발성 발작이 특징인 신경질환으로 뇌의 비정상적인 전기적 활동으로 인해 경련, 의식 소실, 감각 장애 및 행동 장애 등 다양한 증상을 유발하는 질환입니다. 간질의 유병률 증가 요인으로는 뇌손상 및 뇌졸중 환자의 생존율 향상, 노인 인구 증가 등을 들 수 있습니다. 항간질약(AED)을 중심으로 한 효과적인 간질 발작 치료는 발작의 빈도와 중증도를 크게 감소시켜 환자의 일상생활 기능과 전반적인 웰빙을 보장합니다. 예를 들어 2024년 2월 현재 세계보건기구(WHO)에 따르면 전 세계에서 약 5,000만 명의 간질 환자가 있으며, 매년 약 500만 명이 새롭게 간질 진단을 받고 있습니다. 따라서 간질 발생률 증가는 간질 발작 치료 시장 확대에 박차를 가하고 있습니다.

간질 발작 치료 시장의 주요 업체들은 특히 기존 항간질제에 반응하지 않는 환자들을 위해 대마 기반 의약품과 같은 대체 치료 솔루션을 개발하기 위해 기술 혁신을 추진하고 있습니다. 대마 식물에서 추출한 대마 기반 의약품은 카나비노이드의 치료적 특성을 이용하여 주로 항경련 작용을 통해 간질을 포함한 다양한 질환을 치료합니다. 예를 들어 2024년 1월 액멘티스 헬스케어 리미티드는 레녹스-가스토 증후군, 드라베 증후군, 결절성 경화증 복합체 등 소아 간질 발작을 관리하기 위해 인도 식약처의 승인을 받은 경구용 대마 식물 유래 의약품 클라세피(Kracepi)를 출시했습니다. 출시했습니다. 클라세피는 테트라하이드로칸나비놀(THC) 함량을 최소화한 약물로, 특히 기존 치료법이 효과가 없는 경우 발작 완화에 효과적인 것으로 나타났습니다.

목차

제1장 개요

제2장 시장의 특징

제3장 시장 동향과 전략

제4장 시장 - 금리, 인플레이션, 지정학, 신형 코로나바이러스 및 경기회복이 시장에 미치는 영향을 포함한 거시경제 시나리오

제5장 세계의 성장 분석과 전략 분석 프레임워크

제6장 시장 세분화

제7장 지역별·국가별 분석

제8장 아시아태평양 시장

제9장 중국 시장

제10장 인도 시장

제11장 일본 시장

제12장 호주 시장

제13장 인도네시아 시장

제14장 한국 시장

제15장 서유럽 시장

제16장 영국 시장

제17장 독일 시장

제18장 프랑스 시장

제19장 이탈리아 시장

제20장 스페인 시장

제21장 동유럽 시장

제22장 러시아 시장

제23장 북미 시장

제24장 미국 시장

제25장 캐나다 시장

제26장 남미 시장

제27장 브라질 시장

제28장 중동 시장

제29장 아프리카 시장

제30장 경쟁 구도와 기업 개요

제31장 기타 대기업과 혁신적 기업

제32장 세계의 시장 경쟁 벤치마킹과 대시보드

제33장 주요 합병과 인수

제34장 최근 시장 동향

제35장 시장의 잠재력이 높은 국가, 부문, 전략

제36장 부록

KSA
영문 목차

영문목차

Epileptic seizure treatment encompasses medical interventions and therapies aimed at managing and controlling seizures in individuals with epilepsy, a neurological disorder characterized by recurrent and unpredictable seizures. Treatment options may include medications, lifestyle modifications, dietary therapies, and other interventions tailored to each patient's specific needs, with the goal of reducing seizure frequency and severity and improving overall quality of life.

The main types of epileptic seizure treatment include established treatment practices, emerging drugs, and individualized therapies. Treatment practices involve methodologies used by healthcare professionals to manage symptoms, including pharmacological interventions, surgical procedures, and non-pharmacological therapies. These treatments address various seizure types, such as partial, generalized, and unclassified seizures, and can be administered via oral or buccal, nasal, rectal, or parenteral routes. Distribution channels include hospital pharmacies, retail pharmacies, and online pharmacies.

The epileptic seizures treatment market research report is one of a series of new reports from The Business Research Company that provides epileptic seizures treatment market statistics, including epileptic seizures treatment industry global market size, regional shares, competitors with an epileptic seizures treatment market share, detailed epileptic seizures treatment market segments, market trends and opportunities, and any further data you may need to thrive in the epileptic seizures treatment industry. This epileptic seizures treatment market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The epileptic seizures treatment market size has grown strongly in recent years. It will grow from $3.42 billion in 2024 to $3.66 billion in 2025 at a compound annual growth rate (CAGR) of 6.9%. The growth in the historic period can be attributed to advancements in antiepileptic drugs (AEDs), research breakthroughs in epilepsy treatment, increased awareness and education, expanded access to healthcare, and a rise in the prevalence of epilepsy.

The epileptic seizures treatment market size is expected to see strong growth in the next few years. It will grow to $4.72 billion in 2029 at a compound annual growth rate (CAGR) of 6.6%. The growth in the forecast period can be attributed to precision medicine approaches, emerging therapeutic modalities, telemedicine and remote monitoring, healthcare integration and multidisciplinary care, and regulatory support and incentives. Major trends in the forecast period include personalized medicine, integration of digital health solutions, emerging therapeutic modalities, focus on comorbidities and quality of life, and regulatory support and market access.

The increasing incidence of epilepsy is anticipated to drive the growth of the market for treating epileptic seizures in the future. Epilepsy, a neurological disorder characterized by recurrent, unprovoked seizures, stems from abnormal electrical activity in the brain, leading to various symptoms such as convulsions, loss of consciousness, and sensory or behavioral disturbances. Factors contributing to the rising prevalence of epilepsy include improved survival rates among individuals with brain injuries or strokes and a growing elderly population. Effective treatment of epileptic seizures, primarily through antiepileptic drugs (AEDs), can significantly reduce their frequency and severity, thus ensuring patients' daily functioning and overall well-being. For instance, as of February 2024, the World Health Organization reported approximately 50 million people worldwide suffering from epilepsy, with about 5 million new diagnoses annually. Hence, the increasing incidence of epilepsy is fueling the expansion of the market for treating epileptic seizures.

Key players in the epileptic seizures treatment market are innovating to develop alternative treatment solutions, such as cannabis-based medications, particularly for patients unresponsive to traditional antiseizure drugs. Cannabis-based drugs, derived from the cannabis plant, harness the therapeutic properties of cannabinoids to address various medical conditions, including epilepsy, primarily for their anticonvulsant effects. For example, in January 2024, Akumentis Healthcare Ltd. introduced Clasepi, an orally administered cannabis plant-based medication approved by India's Drug Controller General to manage seizures, especially in children with conditions such as Lennox-Gastaut syndrome, Dravet syndrome, or Tuberous Sclerosis Complex. Clasepi, containing minimal tetrahydrocannabinol (THC) content, has shown efficacy in reducing seizures, particularly in cases where conventional treatments have proven ineffective, albeit it's cautioned for individuals allergic to cannabidiol or its constituents.

In March 2022, UCB SA bolstered its presence in the epileptic seizures treatment market by acquiring Zogenix Inc. for approximately $1.9 billion. This strategic move not only expands UCB's revenue potential but also grants access to promising epilepsy treatments, reinforcing its commitment to offering innovative solutions for severe forms of epilepsy such as Dravet syndrome. Zogenix Inc., a US-based biopharmaceutical company specializing in drugs and therapies for rare diseases, particularly rare pediatric epilepsy, thus enhances UCB's portfolio and strengthens its position in addressing the unmet medical needs of epilepsy patients.

Major companies operating in the epileptic seizures treatment market are Pfizer Inc., Johnson & Johnson Service Inc., Sanofi S.A., Abbott Laboratories, Novartis AG, GlaxoSmithKline plc., Takeda Pharmaceutical Co. Ltd., Medtronic plc, GE HealthCare Technologies Inc., Teva Pharmaceutical Industries Ltd., Bausch Health Companies Inc., UCB S.A., Eisai Co. Ltd., Sumitomo Dainippon Pharma Co. Ltd., Dragerwerk AG & Co.KGaA, H. Lundbeck A/S, Apotex Inc., Masimo Corporation, Fisher & Paykel Healthcare Limited, Inspiration Healthcare Group Plc., Phoenix Medical Systems (P) Ltd., Marinus Pharmaceuticals Inc., Alexza Pharmaceuticals Inc., Neurelis Inc., Veriton Pharma

North America was the largest region in the epileptic seizures treatment market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the epileptic seizures treatment market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the epileptic seizures treatment market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The epileptic seizures treatment market consists of revenues earned by entities by providing services, such as medication management, rehabilitation services, diagnostic services, telemedicine, and remote monitoring services. The market value includes the value of related goods sold by the service provider or included within the service offering. The epileptic seizures treatment market also includes sales of anti-epileptic drugs, surgical implants, ketogenic diet products, seizure alarms, and vagus nerve stimulators which are used in providing the services. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Epileptic Seizures Treatment Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on epileptic seizures treatment market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

Where is the largest and fastest growing market for epileptic seizures treatment ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The epileptic seizures treatment market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

Scope

Table of Contents

1. Executive Summary

2. Epileptic Seizures Treatment Market Characteristics

3. Epileptic Seizures Treatment Market Trends And Strategies

4. Epileptic Seizures Treatment Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Covid And Recovery On The Market

5. Global Epileptic Seizures Treatment Growth Analysis And Strategic Analysis Framework

6. Epileptic Seizures Treatment Market Segmentation

7. Epileptic Seizures Treatment Market Regional And Country Analysis

8. Asia-Pacific Epileptic Seizures Treatment Market

9. China Epileptic Seizures Treatment Market

10. India Epileptic Seizures Treatment Market

11. Japan Epileptic Seizures Treatment Market

12. Australia Epileptic Seizures Treatment Market

13. Indonesia Epileptic Seizures Treatment Market

14. South Korea Epileptic Seizures Treatment Market

15. Western Europe Epileptic Seizures Treatment Market

16. UK Epileptic Seizures Treatment Market

17. Germany Epileptic Seizures Treatment Market

18. France Epileptic Seizures Treatment Market

19. Italy Epileptic Seizures Treatment Market

20. Spain Epileptic Seizures Treatment Market

21. Eastern Europe Epileptic Seizures Treatment Market

22. Russia Epileptic Seizures Treatment Market

23. North America Epileptic Seizures Treatment Market

24. USA Epileptic Seizures Treatment Market

25. Canada Epileptic Seizures Treatment Market

26. South America Epileptic Seizures Treatment Market

27. Brazil Epileptic Seizures Treatment Market

28. Middle East Epileptic Seizures Treatment Market

29. Africa Epileptic Seizures Treatment Market

30. Epileptic Seizures Treatment Market Competitive Landscape And Company Profiles

31. Epileptic Seizures Treatment Market Other Major And Innovative Companies

32. Global Epileptic Seizures Treatment Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Epileptic Seizures Treatment Market

34. Recent Developments In The Epileptic Seizures Treatment Market

35. Epileptic Seizures Treatment Market High Potential Countries, Segments and Strategies

36. Appendix

(주)글로벌인포메이션 02-2025-2992 kr-info@giikorea.co.kr
ⓒ Copyright Global Information, Inc. All rights reserved.
PC버전 보기